These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 4756582

  • 1. [Metabolism of vitamin B6, citric and oxalic acids, calcium and magnesium in nephrolithiasis].
    Izashvili NP, Kasabian EV.
    Urol Nefrol (Mosk); 1973; 38(3):9-13. PubMed ID: 4756582
    [No Abstract] [Full Text] [Related]

  • 2. Oxalic acid, calcium, and phosphorus in the renal papilla of normal and stone forming rats.
    Wright RJ, Hodgkinson A.
    Invest Urol; 1972 Mar; 9(5):369-75. PubMed ID: 5016022
    [No Abstract] [Full Text] [Related]

  • 3. [Animal-experiment studies on the effect of magnesium and vitamin B 6 on calcium-oxalate nephrolithiasis].
    Schneider HJ, Hesse A, Berg W, Kirsten J, Nickel H.
    Z Urol Nephrol; 1977 Jun; 70(6):419-27. PubMed ID: 906678
    [Abstract] [Full Text] [Related]

  • 4. INTERELATIONS AMONG MAGNESIUM, VITAMIN B6, SULFUR AND PHOSPHORUS IN THE FORMATION OF KIDNEY STONES IN THE RAT.
    Faragalla FF, Gershoff SN.
    J Nutr; 1963 Sep; 81():60-6. PubMed ID: 14061404
    [No Abstract] [Full Text] [Related]

  • 5. [Metabolic studies in patients with urinary calculi].
    Bach D.
    Z Urol Nephrol; 1982 Jul; 75(7):545-52. PubMed ID: 7148172
    [No Abstract] [Full Text] [Related]

  • 6. Is there a need for medical evaluation and treatment of nephrolithiasis in the "age of lithotripsy"?
    Preminger GM.
    Semin Urol; 1994 Feb; 12(1):51-64. PubMed ID: 8197337
    [No Abstract] [Full Text] [Related]

  • 7. Production of urinary calculi in vitamin B6-deficient male, female and castrated male rats.
    Gershoff SN.
    J Nutr; 1970 Jan; 100(1):117-22. PubMed ID: 5412125
    [No Abstract] [Full Text] [Related]

  • 8. The effect of magnesium and pyridoxine on formation of calcium oxalate sones in man.
    Nutr Rev; 1967 Oct; 25(10):304-5. PubMed ID: 4861850
    [No Abstract] [Full Text] [Related]

  • 9. Calcium oxalate lithiasis produced by pyridoxine deficiency and inhibition with high magnesium diets.
    Lyon ES, Borden TA, Ellis JE, Vermeulen CW.
    Invest Urol; 1966 Sep; 4(2):133-42. PubMed ID: 5926625
    [No Abstract] [Full Text] [Related]

  • 10. Effect of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones.
    Gershoff SN, Prien EL.
    Am J Clin Nutr; 1967 May; 20(5):393-9. PubMed ID: 6023850
    [No Abstract] [Full Text] [Related]

  • 11. [Oxalate metabolism and thiamine-pyridoxine intake of the rat].
    Hauschildt S, Rudolph R, Feldheim W.
    Int J Vitam Nutr Res; 1972 May; 42(3):457-67. PubMed ID: 5086650
    [No Abstract] [Full Text] [Related]

  • 12. [Metabolic causes of nephrolithiasis].
    Kokot F.
    Pol Przegl Chir; 1977 Feb; 49(2A):219-226. PubMed ID: 840788
    [No Abstract] [Full Text] [Related]

  • 13. The urinary excretion of oxalic acid and magnesium in oxalate urolithiasis.
    Takasaki E, Shimano E.
    Invest Urol; 1967 Nov; 5(3):303-12. PubMed ID: 6073639
    [No Abstract] [Full Text] [Related]

  • 14. The effects of magnesium and pH on experimental calcium oxalate stone disease.
    Borden TA, Lyon ES.
    Invest Urol; 1969 Jan; 6(4):412-22. PubMed ID: 5773525
    [No Abstract] [Full Text] [Related]

  • 15. [Kidney calculi: pathogenesis and treatment].
    Kokot F, Kokot S.
    Przegl Lek; 1988 Jan; 45(5):469-74. PubMed ID: 3227117
    [No Abstract] [Full Text] [Related]

  • 16. [Calcium, phosphorus and magnesium metabolism in patients with recurrent nephrolithiasis].
    Kwias Z, Twardosz W.
    Pol Przegl Chir; 1976 Jan; 48(5):605-10. PubMed ID: 1272989
    [No Abstract] [Full Text] [Related]

  • 17. Mechanism of allopurinol action in calcium oxalate stone formers.
    Tomlinson B, Al-Khader A, Cohen SL, Kasidas GP, Krywawych S, Edgar L, Rose GA.
    Proc Eur Dial Transplant Assoc; 1981 Jan; 18():556-60. PubMed ID: 6276882
    [No Abstract] [Full Text] [Related]

  • 18. The effect of some drugs on oxalic acid excretion in urine.
    el-Dakhakhny M, el-Sayed M.
    Arzneimittelforschung; 1970 Feb; 20(2):264-7. PubMed ID: 4392557
    [No Abstract] [Full Text] [Related]

  • 19. [Current trends in phosphotherapy. IV. Treatment of oxalic lithiasis].
    Eisinger J, d' Omezon Y, Recordier AM.
    Mars Med; 1971 Feb; 108(9):605-8. PubMed ID: 5120435
    [No Abstract] [Full Text] [Related]

  • 20. Oxalate metabolism. II.
    Hagler L, Herman RH.
    Am J Clin Nutr; 1973 Aug; 26(8):882-9. PubMed ID: 4578537
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.